Looks for early signs of lung and heart disease using scans and tests
Studies biomarkers for lung disease, heart disease and lung cancer in adults.
Plain-language title generated from the registry record
Registry title: An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
Key facts
- Where
- Lund, SwedenSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 45 to 75 years. It is an observational study of COPD, heart and blood vessel disease, and lung cancer.
- Age
- 45 to 75 years
- Sex
- All sexes can join.
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 75 years old?
Source: NCT01460264, who can take part
Where in Sweden
- Skåne University HospitalLund, SwedenNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Region Skane
- Trial code
- NCT01460264
- Record updated
- 29 August 2025
- Original description
This is an observational study aiming to identify and validate biomarkers (including imaging and clinical descriptors) for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) and lung cancer.Read full original descriptionShow less
BIG3 - An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
This is an observational study aiming to identify and validate biomarkers (including imaging and clinical descriptors) for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) and lung cancer.
Inclusion: 45-75 years.